Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 20

Publication Record

Connections

Aldosterone in vascular and metabolic dysfunction.
Luther JM
(2016) Curr Opin Nephrol Hypertens 25: 16-21
MeSH Terms: Adipocytes, Aldosterone, Animals, Blood Glucose, Blood Pressure, Coronary Circulation, Diabetic Nephropathies, Humans, Mineralocorticoid Receptor Antagonists, Muscle, Smooth, Vascular, Receptors, Mineralocorticoid, Vascular Endothelial Growth Factor Receptor-1
Added November 30, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
Brown J, de Boer IH, Robinson-Cohen C, Siscovick DS, Kestenbaum B, Allison M, Vaidya A
(2015) J Clin Endocrinol Metab 100: 490-9
MeSH Terms: African Americans, Aged, Aged, 80 and over, Aldosterone, Angiotensin-Converting Enzyme Inhibitors, Asian Americans, Atherosclerosis, Cross-Sectional Studies, Female, Hispanic or Latino, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Parathyroid Hormone, Renin-Angiotensin System, Whites
Added September 19, 2017
0 Communities
1 Members
0 Resources
17 MeSH Terms
Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans.
Laffer CL, Elijovich F, Eckert GJ, Tu W, Pratt JH, Brown NJ
(2014) J Am Soc Hypertens 8: 475-80
MeSH Terms: Adolescent, Adult, African Americans, Aged, Blood Pressure, Cytochrome P-450 CYP4A, Cytochrome P-450 Enzyme System, DNA, Double-Blind Method, Female, Genetic Variation, Genotype, Humans, Hypertension, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Pilot Projects, Radioimmunoassay, United States, Young Adult
Added February 19, 2015
0 Communities
1 Members
0 Resources
21 MeSH Terms
Is there a new dawn for selective mineralocorticoid receptor antagonism?
Luther JM
(2014) Curr Opin Nephrol Hypertens 23: 456-61
MeSH Terms: Animals, Antihypertensive Agents, Blood Pressure, Blood Vessels, Drug Design, Humans, Hyperkalemia, Hypertension, Mineralocorticoid Receptor Antagonists, Receptors, Mineralocorticoid, Risk Factors, Signal Transduction, Treatment Outcome
Added October 27, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.
Brown NJ
(2013) Nat Rev Nephrol 9: 459-69
MeSH Terms: Aldosterone, Animals, Aromatase Inhibitors, Cardiovascular System, Cytochrome P-450 CYP11B2, Endothelial Cells, Fadrozole, Fibrosis, Humans, Imidazoles, Inflammation, Kidney, Macrophages, Mineralocorticoid Receptor Antagonists, Myocardium, Myocytes, Cardiac, Pyridines, Reactive Oxygen Species, Receptors, Mineralocorticoid, Sodium, Dietary
Added December 10, 2013
0 Communities
1 Members
0 Resources
20 MeSH Terms
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ
(2012) Kidney Int 82: 643-51
MeSH Terms: Aldosterone, Angiotensin II, Animals, Aorta, Biomarkers, Blood Pressure, Cytochrome P-450 CYP11B2, Disease Models, Animal, Fibrosis, Gene Expression Regulation, Heart Diseases, Inflammation, Kidney Diseases, Kidney Glomerulus, Mice, Mice, 129 Strain, Mice, Inbred C57BL, Mineralocorticoid Receptor Antagonists, Myocardium, Receptors, Mineralocorticoid, Renin-Angiotensin System, Sodium Chloride, Dietary, Spironolactone, Time Factors, Vascular Diseases
Added December 10, 2013
2 Communities
2 Members
0 Resources
25 MeSH Terms
Aldosterone and inflammation.
Gilbert KC, Brown NJ
(2010) Curr Opin Endocrinol Diabetes Obes 17: 199-204
MeSH Terms: Aldosterone, Animals, Cytochrome P-450 CYP11B2, Disease Models, Animal, Humans, Inflammation, Mineralocorticoid Receptor Antagonists, Reactive Oxygen Species, Receptor, Angiotensin, Type 1, Receptors, Mineralocorticoid
Added December 10, 2013
0 Communities
1 Members
0 Resources
10 MeSH Terms
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW
(2009) Circulation 119: e391-479
MeSH Terms: Adult, American Heart Association, Cardiology, Disease Progression, Diuretics, Female, Heart Failure, Humans, Hypokalemia, Male, Mineralocorticoid Receptor Antagonists, Terminal Care, United States, Vasodilator Agents
Added March 27, 2014
1 Communities
0 Members
0 Resources
14 MeSH Terms
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ
(2009) Kidney Int 75: 936-44
MeSH Terms: Angiotensin II, Animals, Cytochrome P-450 CYP11B2, Enzyme Inhibitors, Fibrosis, Heart Diseases, Kidney Diseases, Mineralocorticoid Receptor Antagonists, Rats, Sodium Chloride, Dietary, Spironolactone
Added December 10, 2013
1 Communities
3 Members
0 Resources
11 MeSH Terms
Aldosterone and end-organ damage.
Marney AM, Brown NJ
(2007) Clin Sci (Lond) 113: 267-78
MeSH Terms: Aldosterone, Cardiovascular Diseases, Diabetes Mellitus, Endothelium, Vascular, Humans, Kidney, Kidney Diseases, Mineralocorticoid Receptor Antagonists, Myocardium, Receptors, Mineralocorticoid, Renin-Angiotensin System
Added December 10, 2013
0 Communities
1 Members
0 Resources
11 MeSH Terms